K201919 is an FDA 510(k) clearance for the Blue Sky Bio TAD. Classified as Implant, Endosseous, Orthodontic (product code OAT), Class II - Special Controls.
Submitted by Blue Sky Bio, LLC (Libertyville, US). The FDA issued a Cleared decision on December 17, 2020 after a review of 160 days - an extended review cycle.
This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3640 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.
View all Blue Sky Bio, LLC devices